The trading price of Gritstone Bio Inc (NASDAQ:GRTS) floating lower at last check on Monday, July 15, closing at $0.61, -6.02% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $3.33 and a 52-week low of $0.52. Over the past month, the stock has lost -23.88% in value.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Gritstone Bio Inc, whose market valuation is $66.33 million at the time of this writing. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -0.3 per share this quarter, however they have predicted annual earnings per share of -1.08 for current year and -0.99 for next year.
From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue is 15.53M.
On the technical side, indicators suggest GRTS has a 100% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 100% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that GRTS’s price is currently -9.15% off the SMA20 and -19.51% off the SMA50. The RSI metric on the 14-day chart is currently showing 39.42, and weekly volatility stands at 8.90%. When measured over the past 30 days, the indicator reaches 8.55%. Gritstone Bio Inc (NASDAQ:GRTS)’s beta value is currently sitting at 0.51, while the Average True Range indicator is currently displaying 0.06.
To see how Gritstone Bio Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: GRTS stock’s performance was -6.02% at last check in today’s session, and -72.97% in the past year.
An evaluation of the daily trading volume of Gritstone Bio Inc (NASDAQ:GRTS) indicates that the 3-month average is 2.04 million.
Currently, records show that 108.57 million of the company’s shares remain outstanding. The insiders hold 8.23% of outstanding shares, whereas institutions hold 38.92%. However, since the stock’s price has seen -70.05% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
